Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
21.96
+0.11 (0.51%)
Sep 18, 2025, 8:00 AM EDT - Market open

Centessa Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
2,9452,2087772931,012-
Upgrade
Market Cap Growth
72.00%184.18%165.01%-71.03%--
Upgrade
Enterprise Value
2,7971,775579-83433-
Upgrade
Last Close Price
21.8516.757.963.1011.26-
Upgrade
PS Ratio
187.63-113.40---
Upgrade
PB Ratio
8.485.503.290.872.06-
Upgrade
P/TBV Ratio
8.495.503.290.872.06-
Upgrade
EV/Sales Ratio
186.46-84.53---
Upgrade
Debt / Equity Ratio
0.340.290.360.210.151.82
Upgrade
Asset Turnover
0.03-0.02---
Upgrade
Quick Ratio
9.939.107.5110.9724.841.18
Upgrade
Current Ratio
10.129.258.0011.4225.521.30
Upgrade
Return on Equity (ROE)
-72.92%-73.93%-52.79%-52.24%-154.41%-
Upgrade
Return on Assets (ROA)
-28.96%-26.82%-26.61%-24.48%-27.16%-
Upgrade
Return on Capital (ROIC)
-30.88%-29.91%-29.46%-27.01%-30.24%-
Upgrade
Earnings Yield
-7.86%-10.67%-19.44%-73.73%-37.73%-
Upgrade
FCF Yield
-4.92%-6.43%-20.65%-68.77%-13.47%-
Upgrade
Buyback Yield / Dilution
-27.54%-19.02%-2.97%-24.26%-401.11%-
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q